Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Authors

• E. O. Hexner
• C. Serdikoff
• M. Jan
• Stephen G. Emerson, Haverford College

Document Type

Journal Article

Role

Author

Published In

Blood

Volume

111

First Page

5663

Last Page

5671

Publication Date

2008

Suggested Citation

Hexner, Elizabeth O., et al. "Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders." Blood 111.12 (2008): 5663-5671.